{
    "nctId": "NCT00584766",
    "briefTitle": "Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer",
    "officialTitle": "Intensive Combination Chemotherapy With Autologous Bone Marrow Rescue for Metastatic Breast Cancer After Intitial Cytoreduction With Standard Agents: A Phase II Study",
    "overallStatus": "COMPLETED",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 21,
    "primaryOutcomeMeasure": "Quality of maximal response; time to initial disease progression; and overall survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* breast carcinoma at first clinical evidence of metastatic disease\n* must have measurable disease by physical exam, x-ray, or scan\n* Age \\< or equal to 55\n* performance status 0-2\n\nExclusion Criteria:\n\n* can't have had more than one prior chemotherapy regimen\n* can't have had concurrent hormonal therapy\n* no brain metastases\n* no previous pelvic radiation\n* no history of another malignancy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}